Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	602.46	1927.98	-274.46
Graham Fair Price	0.69	5998.18	5956.79
PEG	404.54	-1.69	0.34
Price/Book	16.41	0.38	0.33
Price/Cash Flow	inf	0.00	72.16
Prices/Earnings	31.46	8.88	6.75
Price/Sales	37.59	5.45	3.96
Price/FCF	inf	0.00	72.16
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-7.33	0.93	1.00
Operating Margin	21616.91	0.22	< 0.005
ROA	-6.29	< 0.005	< 0.005
ROE	0.01	0.01	-11.45
ROIC	< 0.005	< 0.005	18233.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	-0.04	-58.89
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.67	197.60	29540.00
EPS QOQ	0.20	-0.05	-73.94
FCF QOQ	< 0.005	-1.00	-23550.00
Revenue QOQ	0.08	-0.09	17.59
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.57	0.56	-2.14
Quick Ratio	-0.20	0.20	-1.59
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	11437.77	12239.22	7.01
Cash	-26096.04	26686.99	2.26
Capex	0.00	0.00	0.00
Free Cash Flow	51.62	0.00	inf
Revenue	939.92	850.91	-9.47
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.21	0.20	-3.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-424.35	3293.60	676.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating